Home
RCUS
RCUS News

Latest Arcus Biosciences Inc. (RCUS) News on November 21, 2024

Business Wire

2 days ago

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Argus Research

9 days ago

RCUS: Raising target price to $18.00

Business Wire

9 days ago

Arcus Biosciences Announces New Employment Inducement Grants

Analysts Have Made A Financial Statement On Arcus Biosciences, Inc.'s (NYSE:RCUS) Third-Quarter Report

Simply Wall St.

12 days ago

Analysts Have Made A Financial Statement On Arcus Biosciences, Inc.'s (NYSE:RCUS) Third-Quarter Report

Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

GuruFocus.com

15 days ago

Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates

Zacks

15 days ago

Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates

Business Wire

15 days ago

Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update

Argus Research

16 days ago

RCUS: Lowering target price to $16.00

Business Wire

16 days ago

Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer

What To Expect From Arcus Biosciences Inc (RCUS) Q3 2024 Earnings

GuruFocus.com

16 days ago

What To Expect From Arcus Biosciences Inc (RCUS) Q3 2024 Earnings

Regeneron (REGN) Tops Q3 Earnings and Revenue Estimates

Zacks

21 days ago

Regeneron (REGN) Tops Q3 Earnings and Revenue Estimates

Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for

Zacks

22 days ago

Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for

Business Wire

22 days ago

Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting

Exelixis (EXEL) Q3 Earnings and Revenues Beat Estimates

Zacks

23 days ago

Exelixis (EXEL) Q3 Earnings and Revenues Beat Estimates

Business Wire

a month ago

Arcus Biosciences Announces New Employment Inducement Grants

MT Newswires

a month ago

Arcus Biosciences Reports 'Encouraging' First Data for Casdatifan in Patients With Metastatic Kidney Cancer

Business Wire

a month ago

First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer

Business Wire

a month ago

Arcus Biosciences to Host Conference Call to Discuss Third-Quarter 2024 Financial Results and Pipeline Update

State Street Corp's Strategic Adjustment in Arcus Biosciences Holdings

GuruFocus.com

a month ago

State Street Corp's Strategic Adjustment in Arcus Biosciences Holdings

Arcus Biosciences Inc (RCUS) Q2 2024 Earnings Call Highlights: Strategic Advancements Amid ...

GuruFocus.com

a month ago

Arcus Biosciences Inc (RCUS) Q2 2024 Earnings Call Highlights: Strategic Advancements Amid ...

Business Wire

a month ago

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc.'s (NYSE:RCUS) Intrinsic Value Is Potentially 30% Above Its Share Price

Simply Wall St.

a month ago

Arcus Biosciences, Inc.'s (NYSE:RCUS) Intrinsic Value Is Potentially 30% Above Its Share Price

Business Wire

a month ago

Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium

Argus Research

a month ago

RCUS: Raising target price to $18.00

MT Newswires

a month ago

Wells Fargo Initiates Arcus Biosciences at Overweight With $29 Price Target

MT Newswires

2 months ago

Arcus Biosciences, AstraZeneca Collaborate on Developing Carcinoma Treatment

Business Wire

2 months ago

Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma

Business Wire

2 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire

2 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences obtains loan facility with Hercules Capital worth $250m

Pharmaceutical Technology

3 months ago

Arcus Biosciences obtains loan facility with Hercules Capital worth $250m

Argus Research

3 months ago

RCUS: Lowering target price to $18.00

MT Newswires

3 months ago

Arcus Biosciences Gets Up to $250 Million Term Loan Facility From Hercules Capital

Business Wire

3 months ago

Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital

Business Wire

3 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire

3 months ago

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Argus Research

3 months ago

RCUS: Raising target price to $19.00

Nuntius partners with Taiho to develop mRNA cancer therapies

Pharmaceutical Technology

3 months ago

Nuntius partners with Taiho to develop mRNA cancer therapies

Arcus Biosciences Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Arcus Biosciences Second Quarter 2024 Earnings: Beats Expectations

We're Not Very Worried About Arcus Biosciences' (NYSE:RCUS) Cash Burn Rate

Simply Wall St.

3 months ago

We're Not Very Worried About Arcus Biosciences' (NYSE:RCUS) Cash Burn Rate

Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates

Zacks

3 months ago

Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates

Business Wire

3 months ago

Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates

Zacks

3 months ago

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates

Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

4 months ago

Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Zacks

4 months ago

Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

GlobeNewswire

4 months ago

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

Business Wire

4 months ago

Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update

Argus Research

4 months ago

RCUS: Rating increased to a HOLD

Argus Research

4 months ago

RCUS: Raising target price to $13.00

Argus Research

4 months ago

RCUS: Lowering target price to $11.00

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

Pharmaceutical Technology

4 months ago

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

MT Newswires

4 months ago

Arcus Biosciences Says Taiho Has Exercised Option for Exclusive License to Quemliclustat in Japan

Business Wire

4 months ago

Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia

MT Newswires

5 months ago

iTeos, Arcus Shares Drop After Genentech's Lung Cancer Study Misses Endpoints

Business Wire

5 months ago

Arcus Biosciences Announces New Employment Inducement Grants

MT Newswires

5 months ago

Truist Lowers Price Target on Arcus Biosciences to $44 From $50, Maintains Buy Rating

Business Wire

5 months ago

Arcus Biosciences Announces New Employment Inducement Grants

MT Newswires

5 months ago

Arcus Completes Enrollment in Phase 3 Trial of Domvanalimab-Containing Regimen for Stomach Cancer

Business Wire

5 months ago

Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers

Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock?

Zacks

5 months ago

Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock?

Business Wire

5 months ago

Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study

Zacks

6 months ago

Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study

MT Newswires

6 months ago

Citigroup Adjusts Arcus Biosciences Price Target to $38 From $36, Maintains Buy Rating

MT Newswires

6 months ago

Gilead Sciences, Arcus Biosciences's Colorectal Cancer Combination Therapy Shows Promise

Business Wire

6 months ago

Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer

Business Wire

6 months ago

Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers

It's Unlikely That Arcus Biosciences, Inc.'s (NYSE:RCUS) CEO Will See A Huge Pay Rise This Year

Simply Wall St.

6 months ago

It's Unlikely That Arcus Biosciences, Inc.'s (NYSE:RCUS) CEO Will See A Huge Pay Rise This Year

Business Wire

6 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Simply Wall St.

6 months ago

Arcus Biosciences, Inc. (NYSE:RCUS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Arcus Biosciences Surpasses Analyst Revenue Forecasts in Q1 2024

GuruFocus.com

6 months ago

Arcus Biosciences Surpasses Analyst Revenue Forecasts in Q1 2024

Arcus Biosciences First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Arcus Biosciences First Quarter 2024 Earnings: Beats Expectations

Business Wire

6 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript

Insider Monkey

6 months ago

Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript

GuruFocus.com

6 months ago

Arcus Biosciences Inc (RCUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates

Zacks

6 months ago

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates

Business Wire

6 months ago

Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update

Business Wire

7 months ago

Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024

Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

7 months ago

Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know

Zacks

7 months ago

Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know

Business Wire

7 months ago

Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting

Argus Research

7 months ago

RCUS: Lowering target price to $16.00

Business Wire

7 months ago

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update

Business Wire

7 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Investors bid Arcus Biosciences (NYSE:RCUS) up US$219m despite increasing losses YoY, taking five-year CAGR to 8.1%

Simply Wall St.

8 months ago

Investors bid Arcus Biosciences (NYSE:RCUS) up US$219m despite increasing losses YoY, taking five-year CAGR to 8.1%

Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)

GuruFocus.com

8 months ago

Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)

Business Wire

8 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)

GuruFocus.com

8 months ago

Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)

Business Wire

8 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Insider Sell: COO Jennifer Jarrett Sells 58,625 Shares of Arcus Biosciences Inc (RCUS)

GuruFocus.com

9 months ago

Insider Sell: COO Jennifer Jarrett Sells 58,625 Shares of Arcus Biosciences Inc (RCUS)

Business Wire

9 months ago

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Business Wire

9 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcript

Wall Street Analysts Think Arcus Biosciences, Inc. (RCUS) Could Surge 151.61%: Read This Before Placing a Bet

Zacks

9 months ago

Wall Street Analysts Think Arcus Biosciences, Inc. (RCUS) Could Surge 151.61%: Read This Before Placing a Bet

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Arcus Biosciences Inc Earnings Call

GuruFocus.com

9 months ago

Arcus Biosciences Inc (RCUS) Reports Fourth-Quarter and Full-Year 2023 Financial Results

Business Wire

9 months ago

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update

Business Wire

9 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire

9 months ago

Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

GlobeNewswire

10 months ago

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks

Insider Monkey

10 months ago

Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks

Archer’s Midnight Aircraft Successfully Completes Phase 1 of Flight Test Program as Company Continues to Advance Towards FAA Certification

Business Wire

10 months ago

Archer’s Midnight Aircraft Successfully Completes Phase 1 of Flight Test Program as Company Continues to Advance Towards FAA Certification

Share on Social Networks: